Which antiemetic and dose is appropriate to treat nausea after ketamine administration?

Prepare for the Annex D Prolonged Casualty Care Test with interactive quizzes. Explore flashcards and multiple-choice questions with hints and detailed explanations. Ace your exam with confidence!

Multiple Choice

Which antiemetic and dose is appropriate to treat nausea after ketamine administration?

Explanation:
The main idea here is choosing an antiemetic that both reliably stops nausea and complements ketamine’s effects in a field setting. Promethazine at 12.5 mg is effective because it blocks multiple pathways involved in nausea (histamine H1, plus anticholinergic and some dopaminergic actions) and also provides a sedative effect that can help calm the patient after ketamine’s dissociative experience. The 12.5 mg dose is a practical single adult dose that balances antiemetic effect with a manageable level of sedation and minimizes respiratory risk. While other options like ondansetron are strong antiemetics, promethazine’s added sedative benefit often makes it the preferred choice in acute casualty care after ketamine. Dramamine or diphenhydramine are less reliably effective and can add more anticholinergic burden or excessive sedation without the same targeted antiemetic impact.

The main idea here is choosing an antiemetic that both reliably stops nausea and complements ketamine’s effects in a field setting. Promethazine at 12.5 mg is effective because it blocks multiple pathways involved in nausea (histamine H1, plus anticholinergic and some dopaminergic actions) and also provides a sedative effect that can help calm the patient after ketamine’s dissociative experience. The 12.5 mg dose is a practical single adult dose that balances antiemetic effect with a manageable level of sedation and minimizes respiratory risk. While other options like ondansetron are strong antiemetics, promethazine’s added sedative benefit often makes it the preferred choice in acute casualty care after ketamine. Dramamine or diphenhydramine are less reliably effective and can add more anticholinergic burden or excessive sedation without the same targeted antiemetic impact.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy